Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced thatBayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration…
Author: OphthalmologyWeb
New Accommodating Implants Expand Options For Presbyopia Correction
Accommodating lenses will become the preferred method of presbyopia correction, according to a speaker here.
A Change in Thinking: Do Not Enlarge the Cataract Wound When Things Go Downhill
Featured Article
NICE Recommends OZURDEX®, An Innovative Treatment For Retinal Vein Occulsion (RVO), A Common Cause Of Vision Loss
Allergan announces today that the National Institute for Health and Clinical Excellence (NICE) has recommended OZURDEX® (dexamethasone 0.7mg intravitreal implant in applicator) for the treatment of macular oedema due to central retinal vein occlusion …
Femtosecond Laser Marks New Era In Cataract Surgery
Femtosecond laser-assisted cataract surgery could present a landmark moment in cataract surgery, according to a speaker here.
Scientists Identify Mutations That Cause Congenital Cataracts
New research identifies genetic mutations that cause an inherited form of cataracts in humans. The study, published online June 2 by Cell Press in the American Journal of Genetics, provides new insight into the understanding of lens transparency and th…
Combined Treatment Might Improve Results In Diabetic Macular Edema
Diabetic macular edema might be more effectively treated with a combined approach, taking into account the complex multifactorial pathogenesis and multiple manifestations of the disease, according to a specialist at the Euretina meeting here.
Retina Holds The Key To Better Vision In Deaf People
People who are deaf benefit from better vision due to the fact their retinas develop differently, experts at the University of Sheffield have shown.
STAAR Surgical Receives Two Key Regulatory Approvals
STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses which go inside the eye, today announced two strategically important regulatory approvals. The Company received CE Mark approval for the KS-…
Kremer LASIK Summer Seminar Attendees Will Receive $1,000 Off Procedure
Kremer Eye Center is hosting the Kremer Summer LASIK Seminar on Thursday, June 9, 2011. Kremer LASIK surgeons will be on-hand to answer medical questions, and attendees will be able to schedule a free consultation and receive $1,000 off a LASIK procedu…
Femtosecond Laser-Assisted Cataract Surgery
In some phases of cataract surgery, the use of the femtosecond laser provides greater degrees of safety and efficacy, but most importantly, the use of this machine will reduce surgical trauma.
Harvard Scientists ‘see’ The Early Cellular Cause Of Dry Eye Disease For The First Time
If you are one of the millions of people around the world who struggle with dry eye disease, good news is on the way. A new research discovery published in the Journal of Leukocyte Biology (https://www.jleukbio.org) offers hope for new drugs that treat…
Some Surgical Procedures Rendered Obsolete By Intravitreal Injection
Many surgical procedures have become outdated since the introduction of intravitreal injections for the treatment of various retinal conditions, a specialist said here.
Novel Pathway Regulating Angiogenesis May Fight Retinal Disease, Cancers
CINCINNATI – Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina – a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers.
DTC Genetic Tests Neither Accurate In Their Predictions Nor Beneficial To Individuals
Amsterdam, The Netherlands: Direct-to-consumer (DTC) genetic tests give inaccurate predictions of disease risks and many European geneticists believe that some of them should be banned, the annual conference of the European Society of Human Genetics wi…
Novel Molecular Pathway Described In Nature Has Possible Implications For Retinal Disease And Cancer Treatment
Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina – a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers.
Webinar: Premium IOLs – The Next Generation
Featured Article
Hope For Advances In Glaucoma Management Fueled By Promising Pipeline
A look at the therapeutic pipeline for glaucoma shows several medications representing new pharmacologic classes are currently being evaluated in clinical trials, said John R. Samples, MD, at ASCRS Glaucoma Day 2011, San Diego.
Webinar: Crystalens Practice Development
Featured Article
Premium Surgery Should Aim For Perfection
The shrinking U.S. dollar is leading to a division between old-fashioned cataract surgery for those who cannot afford newer technology and premium cataract surgery, which is of increasing interest to U.S. surgeons, a clinician said here. John A. Hovane…